Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson's Disease

被引:29
|
作者
Guatteo, Ezia [1 ,2 ]
Berretta, Nicola [2 ]
Monda, Vincenzo [1 ]
Ledonne, Ada [2 ]
Mercuri, Nicola Biagio [2 ,3 ]
机构
[1] Univ Naples Parthenope, Dept Motor Sci & Wellness, I-80133 Naples, Italy
[2] IRCCS Santa Lucia Fdn, Expt Neurol Lab, I-00143 Rome, Italy
[3] Univ Roma Tor Vergata, Dept Syst Med, I-00143 Rome, Italy
关键词
PD toxicity; electrophysiological modifications; firing; excitability; substantia nigra; dopamine; neurotoxin; alpha-synuclein; K-ATP CHANNELS; D-ASPARTATE CURRENTS; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; L-DOPA; MOUSE MODEL; I-H; SYNAPTIC PLASTICITY; OXIDANT STRESS; FIRING PATTERN;
D O I
10.3390/ijms23094508
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The degeneration of nigral dopaminergic neurons is considered the hallmark of Parkinson's disease (PD), and it is triggered by different factors, including mitochondrial dysfunction, Lewy body accumulation, neuroinflammation, excitotoxicity and metal accumulation. Despite the extensive literature devoted to unravelling the signalling pathways involved in neuronal degeneration, little is known about the functional impairments occurring in these cells during illness progression. Of course, it is not possible to obtain direct information on the properties of the dopaminergic cells in patients. However, several data are available in the literature reporting changes in the function of these cells in PD animal models. In the present manuscript, we focus on dopaminergic neuron functional properties and summarize shared or peculiar features of neuronal dysfunction in different PD animal models at different stages of the disease in an attempt to design a picture of the functional modifications occurring in nigral dopaminergic neurons during disease progression preceding their eventual death.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Apoptotic degeneration of nigral dopaminergic neurons in Parkinson's disease
    Anglade, P
    Vyas, S
    JavoyAgid, F
    Herrero, MT
    Michel, PP
    Marquez, J
    MouattPrigent, A
    Ruberg, M
    Hirsch, EC
    Agid, Y
    NEUROLOGY, 1996, 46 (02) : 6136 - 6136
  • [2] Nigral Neuroinflammation and Dopaminergic Neurons in Parkinson's Disease and Atypical Parkinsonisms
    Backman, Emmilotta A.
    Gardberg, Maria
    Luntamo, Laura
    Peurla, Markus
    Vahlberg, Tero
    Borghammer, Per
    Stefanova, Nadia
    Wenning, Gregor
    Kaasinen, Valtteri
    ANNALS OF NEUROLOGY, 2025,
  • [3] Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease
    Bensaid, Manale
    Michel, Patrick P.
    Clark, Stewart D.
    Hirsch, Etienne C.
    Francois, Chantal
    EXPERIMENTAL NEUROLOGY, 2016, 275 : 209 - 219
  • [4] Nicotinic Receptor Stimulation Protects Nigral Dopaminergic Neurons in Rotenone-induced Parkinson's Disease Models
    Takeuchi, Hiroki
    Yanagida, Takashi
    Inden, Masatoshi
    Takata, Kazuyuki
    Kitamura, Yoshihisa
    Yamakawa, Kentaro
    Sawada, Hideyuki
    Izumi, Yasuhiko
    Yamamoto, Noriyuki
    Kihara, Takeshi
    Uemura, Kengo
    Inoue, Haruhisa
    Taniguchi, Takashi
    Akaike, Akinori
    Takahashi, Ryosuke
    Shimohama, Shun
    JOURNAL OF NEUROSCIENCE RESEARCH, 2009, 87 (02) : 576 - 585
  • [5] Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models
    Hiroki, Takeuchi
    Kitamura, Yoshihisa
    Sawada, Hideyuki
    Uemura, Kengo
    Inoue, Haruhisa
    Taniguchi, Takashi
    Akaike, Akinori
    Takahashi, Ryosuke
    Shimohama, Shun
    NEUROSCIENCE RESEARCH, 2008, 61 : S123 - S123
  • [6] Nurr1 expression in the remaining nigral dopaminergic neurons in Parkinson's disease
    Kompoliti, K
    Chu, Y
    Kordower, J
    MOVEMENT DISORDERS, 2004, 19 : S193 - S193
  • [7] Paroxetine prevents loss of nigral dopaminergic neurons in the MPTP model of Parkinson's disease
    Chung, Y. C.
    Kim, S. R.
    Noh, J. S.
    Chung, Y. K.
    Jin, B. K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S127 - S127
  • [8] Oxidative stress to dopaminergic neurons as models of Parkinson's disease
    Gille, G
    Hung, ST
    Reichmann, H
    Rausch, WD
    STRESS: CURRENT NEUROENDOCRINE AND GENETIC APPROACHES, 2004, 1018 : 533 - 540
  • [9] PUERARIN PROTECTS DOPAMINERGIC NEURONS IN PARKINSON'S DISEASE MODELS
    Zhang, X.
    Xiong, J.
    Liu, S.
    Wang, L.
    Huang, J.
    Liu, L.
    Yang, J.
    Zhang, G.
    Guo, K.
    Zhang, Z.
    Wu, P.
    Wang, D.
    Lin, Z.
    Xiong, N.
    Wang, T.
    NEUROSCIENCE, 2014, 280 : 88 - 98
  • [10] Parkinson's disease: animal models and dopaminergic cell vulnerability
    Blesa, Javier
    Przedborski, Serge
    FRONTIERS IN NEUROANATOMY, 2014, 8